What are Future Directions in Immunotherapy Toxicology?
As cancer immunotherapy continues to evolve, a deeper understanding of the mechanisms underlying irAEs is crucial. Research is focused on identifying biomarkers that predict adverse outcomes, thus allowing for personalized treatment protocols. Additionally, therapeutic strategies to manage irAEs without compromising the efficacy of immunotherapy are under investigation.
